These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2540909)

  • 21. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients.
    Javitt DC
    Curr Opin Psychiatry; 2006 Mar; 19(2):151-7. PubMed ID: 16612195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
    Noda Y; Nabeshima T
    Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
    Di Chiara G; Morelli M
    Adv Neurol; 1993; 60():102-6. PubMed ID: 8093571
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-NMDA receptor antagonists and the development of amygdala kindling.
    Meldrum BS; Dürmüller N
    Epilepsy Res Suppl; 1996; 12():283-91. PubMed ID: 9302527
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptors trigger excitement.
    Barnes DM
    Science; 1988 Jan; 239(4837):254-6. PubMed ID: 2447649
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glutamatergic neurotransmission in schizophrenics].
    Bleich S; Bleich K; Wiltfang J; Maler JM; Kornhuber J
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S56-61. PubMed ID: 11533851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMDA-associated glycine binding site increases in schizophrenic brains.
    Ishimaru M; Kurumaji A; Toru M
    Biol Psychiatry; 1992 Aug; 32(4):379-81. PubMed ID: 1330010
    [No Abstract]   [Full Text] [Related]  

  • 29. Synaptic transmission mediated by ionotropic glutamate, glycine and GABA receptors in the rat's ventral nucleus of the lateral lemniscus.
    Irfan N; Zhang H; Wu SH
    Hear Res; 2005 May; 203(1-2):159-71. PubMed ID: 15855041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
    Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
    Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More dimensions for glutamate toxicity.
    Barnes DM
    Science; 1988 Dec; 242(4885):1509-10. PubMed ID: 2904700
    [No Abstract]   [Full Text] [Related]  

  • 32. Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.
    Riederer P; Lange KW; Kornhuber J; Jellinger K
    J Neural Transm Suppl; 1991; 34():203-10. PubMed ID: 1687783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate and schizophrenia.
    Kornhuber J
    Trends Pharmacol Sci; 1990 Sep; 11(9):357. PubMed ID: 2146789
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperinnervation of orbital frontal cortex in schizophrenia.
    Deakin JF; Slater P; Simpson MD; Royston MC
    Br J Psychiatry; 1990 Sep; 157():459-60. PubMed ID: 1978787
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dysfunction of glutamatergic systems and potential animal models of schizophrenia].
    Mouri A; Noda Y; Mizoguchi H; Nabeshima T
    Nihon Yakurigaku Zasshi; 2006 Jan; 127(1):4-8. PubMed ID: 16508216
    [No Abstract]   [Full Text] [Related]  

  • 36. Selectivity of excitotoxic mechanisms in Alzheimer's disease.
    May PC
    Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolism and functions of brain D-serine in mammals: relevance to neuropsychiatric disorders].
    Nishikawa T
    Seikagaku; 2008 Apr; 80(4):267-76. PubMed ID: 18516904
    [No Abstract]   [Full Text] [Related]  

  • 38. [Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia].
    Nakato K; Harada K; Tobe T; Yamaji T; Takakura S
    Nihon Yakurigaku Zasshi; 2010 Sep; 136(3):128-32. PubMed ID: 20838012
    [No Abstract]   [Full Text] [Related]  

  • 39. Phencyclidine and schizophrenia.
    Kornhuber J
    Am J Psychiatry; 1992 Jun; 149(6):848-9. PubMed ID: 1350430
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenesis of schizophrenia: loss of function of presynaptic inhibitory receptor sites.
    Schnieden H
    Med Hypotheses; 1977; 3(5):205-6. PubMed ID: 198642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.